首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >PNAS Plus: MiR-155–regulated molecular network orchestrates cell fate in the innate and adaptive immune response to Mycobacterium tuberculosis
【2h】

PNAS Plus: MiR-155–regulated molecular network orchestrates cell fate in the innate and adaptive immune response to Mycobacterium tuberculosis

机译:PNAS Plus:MiR-155调控的分子网络在对结核分枝杆菌的固有和适应性免疫应答中协调细胞命运

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The regulation of host–pathogen interactions during Mycobacterium tuberculosis (Mtb) infection remains unresolved. MicroRNAs (miRNAs) are important regulators of the immune system, and so we used a systems biology approach to construct an miRNA regulatory network activated in macrophages during Mtb infection. Our network comprises 77 putative miRNAs that are associated with temporal gene expression signatures in macrophages early after Mtb infection. In this study, we demonstrate a dual role for one of these regulators, miR-155. On the one hand, miR-155 maintains the survival of Mtb-infected macrophages, thereby providing a niche favoring bacterial replication; on the other hand, miR-155 promotes the survival and function of Mtb-specific T cells, enabling an effective adaptive immune response. MiR-155–induced cell survival is mediated through the SH2 domain-containing inositol 5-phosphatase 1 (SHIP1)/protein kinase B (Akt) pathway. Thus, dual regulation of the same cell survival pathway in innate and adaptive immune cells leads to vastly different outcomes with respect to bacterial containment.
机译:结核分枝杆菌(Mtb)感染期间宿主与病原体相互作用的调控仍未解决。 MicroRNA(miRNA)是免疫系统的重要调节剂,因此我们使用系统生物学方法来构建在Mtb感染过程中在巨噬细胞中激活的miRNA调节网络。我们的网络包含77个推定的miRNA,它们与Mtb感染后早期巨噬细胞中的时间基因表达特征相关。在这项研究中,我们证明了这些调节剂之一miR-155的双重作用。一方面,miR-155维持了受Mtb感染的巨噬细胞的存活,从而提供了利于细菌复制的利基;另一方面,miR-155促进Mtb特异性T细胞的存活和功能,从而实现有效的适应性免疫应答。 MiR-155诱导的细胞存活通过包含SH2域的肌醇5-磷酸酶1(SHIP1)/蛋白激酶B(Akt)途径介导。因此,先天性和适应性免疫细胞中相同细胞存活途径的双重调节导致细菌抑制方面的巨大不同。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号